Denna sida på svenska

Per Hall

Professor

About me

After graduation at the University of Lund I started working as a medical oncologist at Department of Oncology, Karolinska Hospital, in 1984. During my sixteen years at Radiumhemmet I initiated and headed the Hereditary Breast Cancer Unit and later the Cancer Epidemiology Unit. I defended my thesis in the field of Radiation Epidemiology in 1991.  

I started working as a full time epidemiologist at the Department of Medical Epidemiology and Biostatistics in 2000. Today my research focus is breast cancer. Part time I am moving back to clinical practice with a focus on clinical research as I just received a part time position at the South General Hospital (Södersjukhuset).

Since 1996 I have coordinated six European Commission and three NIH projects. Besides the ordinary national funding agencies I have received funding from private donations and the Stockholm County Council.

My strength as a researcher is that questions asked and hypothesis generated are all based in my clinical background. I want my results to have clinical implications.

However, research is not the most important part of life, that’s my three sons, two at home and one at the University of Lund.

Education

MD, PhD

Research description

Short presentation of current research

My overall and most important scientific goal is to lower the incidence and mortality of breast cancer, a potentially fatal disease that is increasing dramatically throughout the world. One woman a minute is diagnosed with breast cancer in Europe.

In order to do decrease incidence, a tool that identifies the individual risk of breast cancer has to be identified. Such a tool should answer the question "Who are the women that will be diagnosed with breast cancer?". The risk prediction tool has to include detailed information on lifestyle factors, genetic markers and something called mammographic density. Several of my projects aim to identify these markers. When we are able to identify women at high risk we will offer means to influence the risk as described in the Prisma study below.

The Karma project

The Karma project is conducted in close collaboration with four hospitals in Sweden, Södersjukhuset, Helsingborg, Landskrona and Lund. Women attending a mammography, screening or clinical, at any of these hospitals were invited to participate in the Karma project. Upon acceptance, participants filled out a web-based questionnaire and donate blood. We also ask for informed consent to store the processed and raw mammograms and to link the personal ID to the Swedish Inpatient, Prescription, Cancer, Emigration/Immigration and Cause of Death Registers. Participants are also linked to the nationwide Breast Cancer Registry (INCA). During 27 months, January 2011 – March 2013, 71,876 women chose to participate in Karma.

The Karma cohort is the best characterized breast cancer cohort in the world and a unique resource for future studies of risk and prognosis of breast cancer. Ourselves, we are totally focused on generating a risk prediction model allowing the identification of the individual risk of breast.

An important aspect of the Karma project is that data are shared with researchers outside the group, department and country. We have built the Karma Research Platform that enables outside researchers to browse the content of Karma and request data. Several projects have been initiated ranging from quality of life to exosomes. The only prerequisite, besides ethics, is that results should be fed back in to the database when published, enabling the next generation of researchers to benefit from the data.

The COGS project

The Collaborative Oncological Gene-environment Study, COGS, is a European Commission funded project with the overall objective to identify the genetic determinants of breast, ovarian and prostate cancer.

I coordinated this gigantic effort, including 167 research groups, in close collaboration with Professor Doug Easton in Cambridge. By 2012 more than 250,000 individuals had been genotyped using a tailor made Illumina array, the iCOGS chip, including  200,000 SNPs. The first major publications emerged in March 2013 and can be found in Nature Genetics. To quickly understand the impact of COGS, please see the list below. The number of SNPs identified before and after the initiation of the COGS project are given.

  • Breast cancer: pre-COGS SNPs: 27; COGS SNPs: 92; total number of SNPs: 119
  • Ovarian cancer: pre-COGS SNPs: 4; COGS SNPs: 14; total number of SNPs: 18
  • Prostate cancer: pre-COGS SNPs: 42; COGS SNPs: 48; total number of SNPs: 90

Mammographic density

Mammographic density, the radiolucent part of the mammogram, consists of glandular and connective tissue. Mammographic density is a strong risk factor for breast and is influenced by age, BMI and hormone replacement therapy. The anti-hormonal therapy administrated to breast cancer patients post surgery decreases density. We have recently shown that a density decrease while on adjuvant tamoxifen is a strong prognosticator and influences breast cancer survival beyond 15 years of diagnosis.

Measuring density for all Karma participants where we collected ≈ 500,000 mammograms, could only be done in a fully automated way. We have therefore teamed up with the Volpara company that provide one of the few FDA approved density measurement devices. In our first publication we found that Volpara mimicked the measured results of the “gold standard” Cumulus, that it predicted risk of breast cancer, was influenced by the established genetic markers related to mammographic density and that it was not machine dependent.

Publications

Mammographic density reduction is a prognostic marker of response to adjuvant tamoxifen therapy in postmenopausal patients with breast cancer.
Li J, Humphreys K, Eriksson L, Edgren G, Czene K, Hall P
J. Clin. Oncol. 2013 Jun;31(18):2249-56

Automated measurement of volumetric mammographic density: a tool for widespread breast cancer risk assessment.
Brand J, Czene K, Shepherd J, Leifland K, Heddson B, Sundbom A, et al
Cancer Epidemiol. Biomarkers Prev. 2014 Sep;23(9):1764-72 

The Karisma project

The possible primary preventive measures for breast cancer ranges from increased physical activity to prophylactic mastectomy. However, lifestyle changes such as increased physical activity, weight loss and reduced intake of alcohol will only have minute influence on risk. Prophylactic removal of the breasts will dramatically lower the risk of breast cancer but at a high prize. An alternative would be risk-reducing medication where a number of studies have shown dramatic effects in breast cancer incidence. As an example, tamoxifen administrated to perfectly healthy women reduces the risk of breast cancer with 40-60%.

The Karisma project will be the first project to use a comprehensive risk model for identification of women in need of risk-reducing medication. We will recruit participants directly from the Karma Cohort. Karma participants identified as having a lifetime risk >20% will be invited to Karisma. Before the main Karisma study begins we will identify the tamoxifen dose that has the highest risk reducing effect and the lowest frequency of side effects. The optimal benefit vs risk ratio will be identified using a novel approach where mammographic density is used as a proxy for therapy response.

We have recently received a grant from the Stockholm County Council and the Karisma study will start during 2015.

Radiation epidemiology

I am a professor of radiation epidemiology, lately with a focus on radiation associated late adverse health effects in women diagnosed with breast cancer. Recently, we managed to estimate the dose dependent risk of a myocardial infarction and identify particularly susceptible subgroups of women. This paper has had an enormous influence on how breast cancer patients are treated and has by far the highest citation rate of my papers.

Another important contribution was a paper published in 2004. We managed to show that low doses of ionizing radiation, equivalent to the dose of a CT scan of the skull, delivered in infancy influenced cognitive function in adult life. A finding that changed the way premature babies are handled.

Publications

Risk of ischemic heart disease in women after radiotherapy for breast cancer.
Darby S, Ewertz M, McGale P, Bennet A, Blom-Goldman U, Brønnum D, et al
N. Engl. J. Med. 2013 Mar;368(11):987-98

Effect of low doses of ionising radiation in infancy on cognitive function in adulthood: Swedish population based cohort study.
Hall P, Adami H, Trichopoulos D, Pedersen N, Lagiou P, Ekbom A, et al
BMJ 2004 Jan;328(7430):19

Research group

I conduct most of my projects in close collaboration with Professor Kamila Czene. Our group at the Department of Medical Epidemiology and Biostatistics consists of post docs and students, research nurses, data base managers, project leaders and administrative personnel. Most analyses are conducted in collaboration with statisticians at the department. We both have extensive and intense international collaboration.

Current supervision of PhD students

Mikael Eriksson

Current co-supervision

Fredrik Strand

Documents

Publications

Amount of stroma is associated with mammographic density and stromal expression of oestrogen receptor in normal breast tissues
Gabrielson M, Chiesa F, Paulsson J, Strell C, Behmer C, Ronnow K, et al
Breast cancer research and treatment 2016;158(2):253-61

Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry
Zhao Z, Wen W, Michailidou K, Bolla Mk, Wang Q, Zhang B, et al
Cancer causes & control : CCC 2016;27(5):679-93

Association of infertility and fertility treatment with mammographic density in a large screening-based cohort of women: a cross-sectional study
Lundberg Fe, Johansson Al, Rodriguez-wallberg K, Brand Js, Czene K, Hall P, et al
Breast cancer research : BCR 2016;18(1):36-

Associations of Breast Cancer Risk Prediction Tools With Tumor Characteristics and Metastasis
Holm J, Li J, Darabi H, Eklund M, Eriksson M, Humphreys K, et al
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016;34(3):251-8

BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers
Meeks Hd, Song H, Michailidou K, Bolla Mk, Dennis J, Wang Q, et al
Journal of the National Cancer Institute 2016;108(2):-

Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170
Dunning Am, Michailidou K, Kuchenbaecker Kb, Thompson D, French Jd, Beesley J, et al
Nature genetics 2016;48(4):374-86

CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancer
Thompson Dj, O'mara Ta, Glubb Dm, Painter Jn, Cheng T, Folkerd E, et al
Endocrine-related cancer 2016;23(2):77-91

Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer
Shi J, Zhang Y, Zheng W, Michailidou K, Ghoussaini M, Bolla Mk, et al
International journal of cancer 2016;139(6):1303-17

Five endometrial cancer risk loci identified through genome-wide association analysis
Cheng Th, Thompson Dj, O'mara Ta, Painter Jn, Glubb Dm, Flach S, et al
Nature genetics 2016;48(6):667-74

Genetic predisposition to ductal carcinoma in situ of the breast
Petridis C, Brook Mn, Shah V, Kohut K, Gorman P, Caneppele M, et al
Breast cancer research : BCR 2016;18(1):22-

Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium
Lei J, Rudolph A, Moysich Kb, Behrens S, Goode El, Bolla Mk, et al
Human genetics 2016;135(1):137-54

Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer
Couch Fj, Kuchenbaecker Kb, Michailidou K, Mendoza-fandino Ga, Nord S, Lilyquist J, et al
Nature communications 2016;7():11375-

Infection-related hospitalizations in breast cancer patients: Risk and impact on prognosis
Brand Js, Colzani E, Johansson Al, Giesecke J, Clements M, Bergh J, et al
The Journal of infection 2016;72(6):650-8

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer
Ovarian Cancer Association Consortium Breast Cancer Association Consortium And Consortium Of Modifiers Of Brca1 And Brca2, Hollestelle A, Van Der Baan Fh, Berchuck A, Johnatty Se, Aben Kk, et al
Gynecologic oncology 2016;141(2):386-401

No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing
Easton Df, Lesueur F, Decker B, Michailidou K, Li J, Allen J, et al
Journal of medical genetics 2016;53(5):298-309

Public interest in and acceptability of the prospect of risk-stratified screening for breast and prostate cancer
Koitsalu M, Sprangers Ma, Eklund M, Czene K, Hall P, Gronberg H, et al
Acta oncologica (Stockholm, Sweden) 2016;55(1):45-51

RAD51B in Familial Breast Cancer
Pelttari Lm, Khan S, Vuorela M, Kiiski Ji, Vilske S, Nevanlinna V, et al
PloS one 2016;11(5):e0153788-

The HLA-DQβ1 insertion is a strong achalasia risk factor and displays a geospatial north-south gradient among Europeans
Becker J, Haas Sl, Mokrowiecka A, Wasielica-berger J, Ateeb Z, Bister J, et al
European journal of human genetics : EJHG 2016;24(8):1228-31

A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density
Rudolph A, Fasching Pa, Behrens S, Eilber U, Bolla Mk, Wang Q, et al
Breast cancer research : BCR 2015;17():110-

A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients
Seibold P, Schmezer P, Behrens S, Michailidou K, Bolla Mk, Wang Q, et al
BMC cancer 2015;15():978-

Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy
Lei J, Rudolph A, Moysich Kb, Rafiq S, Behrens S, Goode El, et al
Breast cancer research : BCR 2015;17():18-

Background risk of breast cancer and the association between physical activity and mammographic density
Trinh T, Eriksson M, Darabi H, Bonn Se, Brand Js, Cuzick J, et al
Breast cancer research : BCR 2015;17():50-

Background risk of breast cancer influences the association between alcohol consumption and mammographic density
Trinh T, Christensen Se, Brand Js, Cuzick J, Czene K, Sjolander A, et al
British journal of cancer 2015;113(1):159-65

Breast cancer genetic risk profile is differentially associated with interval and screen-detected breast cancers
Li J, Holm J, Bergh J, Eriksson M, Darabi H, Lindstrom Ls, et al
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2015;26(3):517-22

Breast cancer tumour growth modelling for studying the association of body size with tumour growth rate and symptomatic detection using case-control data
Abrahamsson L, Czene K, Hall P, Humphreys K
Breast cancer research : BCR 2015;17():116-

Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk
Carvajal-carmona Lg, O'mara Ta, Painter Jn, Lose Fa, Dennis J, Michailidou K, et al
Human genetics 2015;134(2):231-45

Common germline polymorphisms associated with breast cancer-specific survival
Pirie A, Guo Q, Kraft P, Canisius S, Eccles Dm, Rahman N, et al
Breast cancer research : BCR 2015;17():58-

Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancer
O'mara Ta, Glubb Dm, Painter Jn, Cheng T, Dennis J, Australian National Endometrial Cancer Study Group (anecs), et al
Endocrine-related cancer 2015;22(5):851-61

Effects of statin use on volumetric mammographic density: results from the KARMA study
Skarping I, Brand Js, Hall P, Borgquist S
BMC cancer 2015;15():435-

Exome sequencing of contralateral breast cancer identifies metastatic disease
Klevebring D, Lindberg J, Rockberg J, Hilliges C, Hall P, Sandberg M, et al
Breast cancer research and treatment 2015;151(2):319-24

Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2
Orr N, Dudbridge F, Dryden N, Maguire S, Novo D, Perrakis E, et al
Human molecular genetics 2015;24(10):2966-84

Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk
Painter Jn, O'mara Ta, Batra J, Cheng T, Lose Fa, Dennis J, et al
Human molecular genetics 2015;24(5):1478-92

Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk
Guo X, Long J, Zeng C, Michailidou K, Ghoussaini M, Bolla Mk, et al
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2015;24(11):1680-91

Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1
Glubb Dm, Maranian Mj, Michailidou K, Pooley Ka, Meyer Kb, Kar S, et al
American journal of human genetics 2015;96(1):5-20

Genetic studies of body mass index yield new insights for obesity biology
Locke Ae, Kahali B, Berndt Si, Justice Ae, Pers Th, Day Fr, et al
Nature 2015;518(7538):197-206

Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer
Michailidou K, Beesley J, Lindstrom S, Canisius S, Dennis J, Lush Mj, et al
Nature genetics 2015;47(4):373-80

Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization
Zhang B, Shu Xo, Delahanty Rj, Zeng C, Michailidou K, Bolla Mk, et al
Journal of the National Cancer Institute 2015;107(11):-

Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk
Lin Wy, Camp Nj, Ghoussaini M, Beesley J, Michailidou K, Hopper Jl, et al
Human molecular genetics 2015;24(1):285-98

Identification of novel genetic markers of breast cancer survival
Guo Q, Schmidt Mk, Kraft P, Canisius S, Chen C, Khan S, et al
Journal of the National Cancer Institute 2015;107(5):-

Identification of two novel mammographic density loci at 6Q25.1
Brand Js, Li J, Humphreys K, Karlsson R, Eriksson M, Ivansson E, et al
Breast cancer research : BCR 2015;17():75-

Increased stomach cancer risk following radiotherapy for testicular cancer
Hauptmann M, Fossa Sd, Stovall M, Van Leeuwen Fe, Johannesen Tb, Rajaraman P, et al
British journal of cancer 2015;112(1):44-51

Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer
Kabisch M, Lorenzo Bermejo J, Dunnebier T, Ying S, Michailidou K, Bolla Mk, et al
Carcinogenesis 2015;36(2):256-71

In Search for the Genetic Basis of Quality of Life in Healthy Swedish Women--A GWAS Study Using the iCOGS Custom Genotyping Array
Schoormans D, Darabi H, Li J, Brandberg Y, Eriksson M, Zwinderman Kh, et al
PloS one 2015;10(10):e0140563-

Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors
Rudolph A, Milne Rl, Truong T, Knight Ja, Seibold P, Flesch-janys D, et al
International journal of cancer 2015;136(6):E685-96

Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair
Day Fr, Ruth Ks, Thompson Dj, Lunetta Kl, Pervjakova N, Chasman Di, et al
Nature genetics 2015;47(11):1294-303

Large-Scale Genomic Analyses Link Reproductive Aging to Hypothalamic Signaling, Breast Cancer Susceptibility, and BRCA1-Mediated DNA Repair EDITORIAL COMMENT
Lifelines Cohort Study, Epic-interact Consortium, Generation Scotland, Aocs Investigators, Kconfab Investigators, Practical Consortium, et al
OBSTETRICAL & GYNECOLOGICAL SURVEY 2015;70(12):758-762

Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1
Cheng Th, Thompson D, Painter J, O'mara T, Gorman M, Martin L, et al
Scientific reports 2015;5():17369-

Novel Associations between Common Breast Cancer Susceptibility Variants and Risk-Predicting Mammographic Density Measures
Stone J, Thompson Dj, Dos Santos Silva I, Scott C, Tamimi Rm, Lindstrom S, et al
Cancer research 2015;75(12):2457-67

Pectoral muscle attenuation as a marker for breast cancer risk in full-field digital mammography
Cheddad A, Czene K, Hall P, Humphreys K
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2015;24(6):985-91

Prediction of breast cancer risk based on profiling with common genetic variants
Mavaddat N, Pharoah Pd, Michailidou K, Tyrer J, Brook Mn, Bolla Mk, et al
Journal of the National Cancer Institute 2015;107(5):-

Predictors of Discontinuation of Adjuvant Hormone Therapy in Patients With Breast Cancer
He W, Fang F, Varnum C, Eriksson M, Hall P, Czene K
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2015;33(20):2262-9

Proteomics profiling identify CAPS as a potential predictive marker of tamoxifen resistance in estrogen receptor positive breast cancer
Johansson Hj, Sanchez Bc, Forshed J, Stal O, Fohlin H, Lewensohn R, et al
Clinical proteomics 2015;12(1):8-

Risk factors and tumor characteristics of interval cancers by mammographic density
Holm J, Humphreys K, Li J, Ploner A, Cheddad A, Eriksson M, et al
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2015;33(9):1030-7

SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival
Jamshidi M, Fagerholm R, Khan S, Aittomaki K, Czene K, Darabi H, et al
Oncotarget 2015;6(35):37979-94

The genetic basis of quality of life in healthy Swedish women: a candidate gene approach
Schoormans D, Li J, Darabi H, Brandberg Y, Sprangers Ma, Eriksson M, et al
PloS one 2015;10(2):e0118292-

The impact of co-morbidity on health-related quality of life in breast cancer survivors and controls
Schoormans D, Czene K, Hall P, Brandberg Y
Acta oncologica (Stockholm, Sweden) 2015;54(5):727-34

The Influence of Age and Sex on Genetic Associations with Adult Body Size and Shape: A Large-Scale Genome-Wide Interaction Study
Winkler Tw, Justice Ae, Graff M, Barata L, Feitosa Mf, Chu S, et al
PLoS genetics 2015;11(10):e1005378-

The SNP rs6500843 in 16p13.3 is associated with survival specifically among chemotherapy-treated breast cancer patients
Fagerholm R, Schmidt Mk, Khan S, Rafiq S, Tapper W, Aittomaki K, et al
Oncotarget 2015;6(10):7390-407

2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy
Li J, Lindstrom Ls, Foo Jn, Rafiq S, Schmidt Mk, Pharoah Pd, et al
Nature communications 2014;5():4051-

A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age
Ahsan H, Halpern J, Kibriya Mg, Pierce Bl, Tong L, Gamazon E, et al
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2014;23(4):658-69

A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium
Milne Rl, Herranz J, Michailidou K, Dennis J, Tyrer Jp, Zamora Mp, et al
Human molecular genetics 2014;23(7):1934-46

Area and volumetric density estimation in processed full-field digital mammograms for risk assessment of breast cancer
Cheddad A, Czene K, Eriksson M, Li J, Easton D, Hall P, et al
PloS one 2014;9(10):e110690-

Automated measurement of volumetric mammographic density: a tool for widespread breast cancer risk assessment
Brand Js, Czene K, Shepherd Ja, Leifland K, Heddson B, Sundbom A, et al
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2014;23(9):1764-72

Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium
Milne Rl, Burwinkel B, Michailidou K, Arias-perez Ji, Zamora Mp, Menendez-rodriguez P, et al
Human molecular genetics 2014;23(22):6096-111

Comparison of fully and semi-automated area-based methods for measuring mammographic density and predicting breast cancer risk
Sovio U, Li J, Aitken Z, Humphreys K, Czene K, Moss S, et al
British journal of cancer 2014;110(7):1908-16

CYP2B6*6 is associated with increased breast cancer risk
Justenhoven C, Pentimalli D, Rabstein S, Harth V, Lotz A, Pesch B, et al
International journal of cancer 2014;134(2):426-30

Decreased birth weight, length, and head circumference in children born by women years after treatment for hyperthyroidism
Ohrling H, Torring O, Yin L, Iliadou An, Tullgren O, Abraham-nordling M, et al
The Journal of clinical endocrinology and metabolism 2014;99(9):3217-23

Defining the role of common variation in the genomic and biological architecture of adult human height
Wood Ar, Esko T, Yang J, Vedantam S, Pers Th, Gustafsson S, et al
Nature genetics 2014;46(11):1173-86

DNA mismatch repair gene MSH6 implicated in determining age at natural menopause
Perry Jr, Hsu Yh, Chasman Di, Johnson Ad, Elks C, Albrecht E, et al
Human molecular genetics 2014;23(9):2490-7

Enhancement of mammographic density measures in breast cancer risk prediction
Cheddad A, Czene K, Shepherd Ja, Li J, Hall P, Humphreys K
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2014;23(7):1314-23

Evaluation of exome sequencing to estimate tumor burden in plasma
Klevebring D, Neiman M, Sundling S, Eriksson L, Darai Ramqvist E, Celebioglu F, et al
PloS one 2014;9(8):e104417-

Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation
Ghoussaini M, Edwards Sl, Michailidou K, Nord S, Cowper-sal Lari R, Desai K, et al
Nature communications 2014;4():4999-

FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium
Agarwal D, Pineda S, Michailidou K, Herranz J, Pita G, Moreno Lt, et al
British journal of cancer 2014;110(4):1088-100

Genetic predisposition to in situ and invasive lobular carcinoma of the breast
Sawyer E, Roylance R, Petridis C, Brook Mn, Nowinski S, Papouli E, et al
PLoS genetics 2014;10(4):e1004285-

Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study
Johnson N, Dudbridge F, Orr N, Gibson L, Jones Me, Schoemaker Mj, et al
Breast cancer research : BCR 2014;16(3):R51-

Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade
Purrington Ks, Slettedahl S, Bolla Mk, Michailidou K, Czene K, Nevanlinna H, et al
Human molecular genetics 2014;23(22):6034-46

Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer
Purrington Ks, Slager S, Eccles D, Yannoukakos D, Fasching Pa, Miron P, et al
Carcinogenesis 2014;35(5):1012-9

Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk
Lindstrom S, Thompson Dj, Paterson Ad, Li J, Gierach Gl, Scott C, et al
Nature communications 2014;5():5303-

Genomic diversity and admixture differs for Stone-Age Scandinavian foragers and farmers
Skoglund P, Malmstrom H, Omrak A, Raghavan M, Valdiosera C, Gunther T, et al
Science (New York, N.Y.) 2014;344(6185):747-50

Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions
Schoeps A, Rudolph A, Seibold P, Dunning Am, Milne Rl, Bojesen Se, et al
Genetic epidemiology 2014;38(1):84-93

Mammographic density phenotypes and risk of breast cancer: a meta-analysis
Pettersson A, Graff Re, Ursin G, Santos Silva Id, Mccormack V, Baglietto L, et al
Journal of the National Cancer Institute 2014;106(5):-

MicroRNA related polymorphisms and breast cancer risk
Khan S, Greco D, Michailidou K, Milne Rl, Muranen Ta, Heikkinen T, et al
PloS one 2014;9(11):e109973-

Pancreatic cancer risk after treatment of Hodgkin lymphoma
Dores Gm, Curtis Re, Van Leeuwen Fe, Stovall M, Hall P, Lynch Cf, et al
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2014;25(10):2073-9

Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche
Perry Jr, Day F, Elks Ce, Sulem P, Thompson Dj, Ferreira T, et al
Nature 2014;514(7520):92-7

Prognostic information of a previously diagnosed sister is an independent prognosticator for a newly diagnosed sister with breast cancer
Lindstrom Ls, Li J, Lee M, Einbeigi Z, Hartman M, Hall P, et al
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2014;25(10):1966-72

Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia
Spurdle Ab, Couch Fj, Parsons Mt, Mcguffog L, Barrowdale D, Bolla Mk, et al
Breast cancer research : BCR 2014;16(6):3419-

Risk of esophageal cancer following radiotherapy for Hodgkin lymphoma
Morton Lm, Gilbert Es, Stovall M, Van Leeuwen Fe, Dores Gm, Lynch Cf, et al
Haematologica 2014;99(10):e193-6

Time-dependent risk of developing distant metastasis in breast cancer patients according to treatment, age and tumour characteristics
Colzani E, Johansson Al, Liljegren A, Foukakis T, Clements M, Adolfsson J, et al
British journal of cancer 2014;110(5):1378-84

Volumetric mammographic density: heritability and association with breast cancer susceptibility loci
Brand Js, Humphreys K, Thompson Dj, Li J, Eriksson M, Hall P, et al
Journal of the National Cancer Institute 2014;106(12):-

A genome-wide association study to identify genetic susceptibility loci that modify ductal and lobular postmenopausal breast cancer risk associated with menopausal hormone therapy use: a two-stage design with replication
Hein R, Flesch-janys D, Dahmen N, Beckmann L, Lindstrom S, Schoof N, et al
Breast cancer research and treatment 2013;138(2):529-42

Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
International Multiple Sclerosis Genetics Consortium (imsgc), Beecham Ah, Patsopoulos Na, Xifara Dk, Davis Mf, Kemppinen A, et al
Nature genetics 2013;45(11):1353-60

Association of CYP2D6 metabolizer status with mammographic density change in response to tamoxifen treatment
Li J, Czene K, Brauch H, Schroth W, Saladores P, Li Y, et al
Breast cancer research : BCR 2013;15(5):R93-

Breast cancer biology and the future of tailored therapies. Introduction
Bergh J, Hall P, Ostman A, Toftgard R
Journal of internal medicine 2013;274(2):102-4

Breast cancer screening: time to target women at risk
Hall P, Easton D
British journal of cancer 2013;108(11):2202-4

Change of mammographic density predicts the risk of contralateral breast cancer--a case-control study
Sandberg Me, Li J, Hall P, Hartman M, Dos-santos-silva I, Humphreys K, et al
Breast cancer research : BCR 2013;15(4):R57-

Comment on "dose-responses from multi-model inference for the non-cancer disease mortality of atomic bomb survivors" (Radiat. Environ. Biophys (2012) 51:165-178) by Schöllnberger et al
Little Mp, Azizova Tv, Bazyka D, Bouffler Sd, Cardis E, Chekin S, et al
Radiation and environmental biophysics 2013;52(1):157-9

Common genetic determinants of breast-cancer risk in East Asian women: a collaborative study of 23 637 breast cancer cases and 25 579 controls
Zheng W, Zhang B, Cai Q, Sung H, Michailidou K, Shi J, et al
Human molecular genetics 2013;22(12):2539-50

Confirmation of the reduction of hormone replacement therapy-related breast cancer risk for carriers of the HSD17B1_937_G variant
Obazee O, Justenhoven C, Winter S, Chang-claude J, Rudolph A, Seibold P, et al
Breast cancer research and treatment 2013;138(2):543-8

Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer
Shen H, Fridley Bl, Song H, Lawrenson K, Cunningham Jm, Ramus Sj, et al
Nature communications 2013;4():1628-

Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors
Nickels S, Truong T, Hein R, Stevens K, Buck K, Behrens S, et al
PLoS genetics 2013;9(3):e1003284-

Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1
Meyer Kb, O'reilly M, Michailidou K, Carlebur S, Edwards Sl, French Jd, et al
American journal of human genetics 2013;93(6):1046-60

Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers
French Jd, Ghoussaini M, Edwards Sl, Meyer Kb, Michailidou K, Ahmed S, et al
American journal of human genetics 2013;92(4):489-503

Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study
Rudolph A, Hein R, Lindstrom S, Beckmann L, Behrens S, Liu J, et al
Endocrine-related cancer 2013;20(6):875-87

Genome-wide association studies identify four ER negative-specific breast cancer risk loci
Garcia-closas M, Couch Fj, Lindstrom S, Michailidou K, Schmidt Mk, Brook Mn, et al
Nature genetics 2013;45(4):392-8

Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk
Couch Fj, Wang X, Mcguffog L, Lee A, Olswold C, Kuchenbaecker Kb, et al
PLoS genetics 2013;9(3):e1003212-

Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture
Berndt Si, Gustafsson S, Magi R, Ganna A, Wheeler E, Feitosa Mf, et al
Nature genetics 2013;45(5):501-12

GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer
Pharoah Pd, Tsai Yy, Ramus Sj, Phelan Cm, Goode El, Lawrenson K, et al
Nature genetics 2013;45(4):362-70

GWAS of 126,559 individuals identifies genetic variants associated with educational attainment
Rietveld Ca, Medland Se, Derringer J, Yang J, Esko T, Martin Nw, et al
Science (New York, N.Y.) 2013;340(6139):1467-71

Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31
Permuth-wey J, Lawrenson K, Shen Hc, Velkova A, Tyrer Jp, Chen Z, et al
Nature communications 2013;4():1627-

Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk
Gaudet Mm, Kuchenbaecker Kb, Vijai J, Klein Rj, Kirchhoff T, Mcguffog L, et al
PLoS genetics 2013;9(3):e1003173-

Incorporating genomics into breast and prostate cancer screening: assessing the implications
Chowdhury S, Dent T, Pashayan N, Hall A, Lyratzopoulos G, Hallowell N, et al
Genetics in medicine : official journal of the American College of Medical Genetics 2013;15(6):423-32

Influence of lifestyle factors on mammographic density in postmenopausal women
Brand Js, Czene K, Eriksson L, Trinh T, Bhoo-pathy N, Hall P, et al
PloS one 2013;8(12):e81876-

Influence of radiotherapy for the first tumor on aggressiveness of contralateral breast cancer
Sandberg Me, Alkner S, Hartman M, Eloranta S, Ryden L, Ploner A, et al
International journal of cancer 2013;132(10):2388-94

Ischemic heart disease after breast cancer radiotherapy
Darby Sc, Ewertz M, Hall P
The New England journal of medicine 2013;368(26):2527-

Large-scale genotyping identifies 41 new loci associated with breast cancer risk
Michailidou K, Hall P, Gonzalez-neira A, Ghoussaini M, Dennis J, Milne Rl, et al
Nature genetics 2013;45(4):353-61

Large-scale genotyping identifies a new locus at 22q13.2 associated with female breast size
Li J, Foo Jn, Schoof N, Varghese Js, Fernandez-navarro P, Gierach Gl, et al
Journal of medical genetics 2013;50(10):666-73

Lessons learned and challenges posed in cancer genetics. Introduction
Simard J, Hall P
Journal of internal medicine 2013;274(5):396-8

Mammographic density and survival in interval breast cancers
Eriksson L, Czene K, Rosenberg Lu, Tornberg S, Humphreys K, Hall P
Breast cancer research : BCR 2013;15(3):R48-

Mammographic density reduction is a prognostic marker of response to adjuvant tamoxifen therapy in postmenopausal patients with breast cancer
Li J, Humphreys K, Eriksson L, Edgren G, Czene K, Hall P
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(18):2249-56

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
Bojesen Se, Pooley Ka, Johnatty Se, Beesley J, Michailidou K, Tyrer Jp, et al
Nature genetics 2013;45(4):371-84

Polymorphisms in oxidative stress-related genes and mortality in breast cancer patients--potential differential effects by radiotherapy?
Seibold P, Hall P, Schoof N, Nevanlinna H, Heikkinen T, Benner A, et al
Breast (Edinburgh, Scotland) 2013;22(5):817-23

Possible influence of mammographic density on local and locoregional recurrence of breast cancer
Eriksson L, Czene K, Rosenberg L, Humphreys K, Hall P
Breast cancer research : BCR 2013;15(4):R56-

Radiation dose and subsequent risk for stomach cancer in long-term survivors of cervical cancer
Kleinerman Ra, Smith Sa, Holowaty E, Hall P, Pukkala E, Vaalavirta L, et al
International journal of radiation oncology, biology, physics 2013;86(5):922-9

Risk of ischemic heart disease in women after radiotherapy for breast cancer
Darby Sc, Ewertz M, Mcgale P, Bennet Am, Blom-goldman U, Bronnum D, et al
The New England journal of medicine 2013;368(11):987-98

Sex-stratified genome-wide association studies including 270,000 individuals show sexual dimorphism in genetic loci for anthropometric traits
Randall Jc, Winkler Tw, Kutalik Z, Berndt Si, Jackson Au, Monda Kl, et al
PLoS genetics 2013;9(6):e1003500-

Stomach cancer risk after treatment for hodgkin lymphoma
Morton Lm, Dores Gm, Curtis Re, Lynch Cf, Stovall M, Hall P, et al
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(27):3369-77

Using patient-reported measurement to pave the path towards personalized medicine
Sprangers Ma, Hall P, Morisky De, Narrow We, Dapueto J
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2013;22(10):2631-7

11q13 is a susceptibility locus for hormone receptor positive breast cancer
Lambrechts D, Truong T, Justenhoven C, Humphreys Mk, Wang J, Hopper Jl, et al
Human mutation 2012;33(7):1123-32

19p13.1 is a triple-negative-specific breast cancer susceptibility locus
Stevens Kn, Fredericksen Z, Vachon Cm, Wang X, Margolin S, Lindblom A, et al
Cancer research 2012;72(7):1795-803

9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium
Warren H, Dudbridge F, Fletcher O, Orr N, Johnson N, Hopper Jl, et al
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2012;21(10):1783-91

A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11
Siddiq A, Couch Fj, Chen Gk, Lindstrom S, Eccles D, Millikan Rc, et al
Human molecular genetics 2012;21(24):5373-84

Breast cancer incidence and case fatality among 4.7 million women in relation to social and ethnic background: a population-based cohort study
Beiki O, Hall P, Ekbom A, Moradi T
Breast cancer research : BCR 2012;14(1):R5-

Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement
Darabi H, Czene K, Zhao W, Liu J, Hall P, Humphreys K
Breast cancer research : BCR 2012;14(1):R25-

Cancer risk after medical exposure to radioactive iodine in benign thyroid diseases: a meta-analysis
Hieu Tt, Russell Aw, Cuneo R, Clark J, Kron T, Hall P, et al
Endocrine-related cancer 2012;19(5):645-55

CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer
Weischer M, Nordestgaard Bg, Pharoah P, Bolla Mk, Nevanlinna H, Van't Veer Lj, et al
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(35):4308-16

Common breast cancer susceptibility variants in LSP1 and RAD51L1 are associated with mammographic density measures that predict breast cancer risk
Vachon Cm, Scott Cg, Fasching Pa, Hall P, Tamimi Rm, Li J, et al
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2012;21(7):1156-66

Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)
Hein R, Maranian M, Hopper Jl, Kapuscinski Mk, Southey Mc, Park Dj, et al
PloS one 2012;7(8):e42380-

Current knowledge and tomorrows challenges of breast, ovarian and prostate cancer genetics
Hall P
Journal of internal medicine 2012;271(4):318-20

Estrogen receptor status in relation to risk of contralateral breast cancer-a population-based cohort study
Sandberg Me, Hall P, Hartman M, Johansson Al, Eloranta S, Ploner A, et al
PloS one 2012;7(10):e46535-

FTO genotype is associated with phenotypic variability of body mass index
Yang J, Loos Rj, Powell Je, Medland Se, Speliotes Ek, Chasman Di, et al
Nature 2012;490(7419):267-72

Genetic variants in ER cofactor genes and endometrial cancer risk
Li Y, Low Hq, Foo Jn, Darabi H, Einarsd?ttir K, Humphreys K, et al
PloS one 2012;7(8):e42445-

Genome-wide association analysis identifies three new breast cancer susceptibility loci
Ghoussaini M, Fletcher O, Michailidou K, Turnbull C, Schmidt Mk, Dicks E, et al
Nature genetics 2012;44(3):312-8

High-throughput mammographic-density measurement: a tool for risk prediction of breast cancer
Li J, Szekely L, Eriksson L, Heddson B, Sundbom A, Czene K, et al
Breast cancer research : BCR 2012;14(4):R114-

Identification of a novel percent mammographic density locus at 12q24
Stevens Kn, Lindstrom S, Scott Cg, Thompson D, Sellers Ta, Wang X, et al
Human molecular genetics 2012;21(14):3299-305

Library preparation and multiplex capture for massive parallel sequencing applications made efficient and easy
Neiman M, Sundling S, Gronberg H, Hall P, Czene K, Lindberg J, et al
PloS one 2012;7(11):e48616-

Mammographic breast density and breast cancer: evidence of a shared genetic basis
Varghese Js, Thompson Dj, Michailidou K, Lindstrom S, Turnbull C, Brown J, et al
Cancer research 2012;72(6):1478-84

Mammographic density and molecular subtypes of breast cancer
Eriksson L, Hall P, Czene K, Dos Santos Silva I, Mccormack V, Bergh J, et al
British journal of cancer 2012;107(1):18-23

[Mammography screening is here to stay. Individual screening programs may be more effective]
Hall P
Läkartidningen 2012;109(13):684-5

Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways
Stolk L, Perry Jr, Chasman Di, He C, Mangino M, Sulem P, et al
Nature genetics 2012;44(3):260-8

No evidence for association of inherited variation in genes involved in mitosis and percent mammographic density
Vachon Cm, Li J, Scott Cg, Hall P, Czene K, Wang X, et al
Breast cancer research : BCR 2012;14(1):R7-

Novel measurements of mammary stem cells in human umbilical cord blood as prospective predictors of breast cancer susceptibility in later life
Qiu L, Low Hp, Chang Ci, Strohsnitter Wc, Anderson M, Edmiston K, et al
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(1):245-50

Origins and genetic legacy of Neolithic farmers and hunter-gatherers in Europe
Skoglund P, Malmstrom H, Raghavan M, Stora J, Hall P, Willerslev E, et al
Science (New York, N.Y.) 2012;336(6080):466-9

Partitioning of excess mortality in population-based cancer patient survival studies using flexible parametric survival models
Eloranta S, Lambert Pc, Andersson Tm, Czene K, Hall P, Bjorkholm M, et al
BMC medical research methodology 2012;12():86-

Prognostic implications of estrogen receptor pattern of both tumors in contralateral breast cancer
Sandberg Me, Hartman M, Klevebring D, Eloranta S, Ploner A, Hall P, et al
Breast cancer research and treatment 2012;134(2):793-800

Risk of treatment-related esophageal cancer among breast cancer survivors
Morton Lm, Gilbert Es, Hall P, Andersson M, Joensuu H, Vaalavirta L, et al
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(12):3081-91

Systematic review and meta-analysis of circulatory disease from exposure to low-level ionizing radiation and estimates of potential population mortality risks
Little Mp, Azizova Tv, Bazyka D, Bouffler Sd, Cardis E, Chekin S, et al
Environmental health perspectives 2012;120(11):1503-11

The dyslexia candidate gene DYX1C1 is a potential marker of poor survival in breast cancer
Rosin G, Hannelius U, Lindstrom L, Hall P, Bergh J, Hartman J, et al
BMC cancer 2012;12():79-

The influence of mammographic density on breast tumor characteristics
Eriksson L, Czene K, Rosenberg L, Humphreys K, Hall P
Breast cancer research and treatment 2012;134(2):859-66

The postmenopausal hormone replacement therapy-related breast cancer risk is decreased in women carrying the CYP2C19*17 variant
Justenhoven C, Obazee O, Winter S, Couch Fj, Olson Je, Hall P, et al
Breast cancer research and treatment 2012;131(1):347-50

The role of genetic breast cancer susceptibility variants as prognostic factors
Fasching Pa, Pharoah Pd, Cox A, Nevanlinna H, Bojesen Se, Karn T, et al
Human molecular genetics 2012;21(17):3926-39

25 years after Chernobyl: lessons for Japan?
Moysich Kb, Mccarthy P, Hall P
The Lancet. Oncology 2011;12(5):416-8

7q21-rs6964587 and breast cancer risk: an extended case-control study by the Breast Cancer Association Consortium
Milne Rl, Lorenzo-bermejo J, Burwinkel B, Malats N, Arias Ji, Zamora Mp, et al
Journal of medical genetics 2011;48(10):698-702

A combined analysis of genome-wide association studies in breast cancer
Li J, Humphreys K, Heikkinen T, Aittomaki K, Blomqvist C, Pharoah Pd, et al
Breast cancer research and treatment 2011;126(3):717-27

A population-based study of copy number variants and regions of homozygosity in healthy Swedish individuals
Teo Sm, Ku Cs, Naidoo N, Hall P, Chia Ks, Salim A, et al
Journal of human genetics 2011;56(7):524-33

Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies
Yang Xr, Chang-claude J, Goode El, Couch Fj, Nevanlinna H, Milne Rl, et al
Journal of the National Cancer Institute 2011;103(3):250-63

Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium
Figueroa Jd, Garcia-closas M, Humphreys M, Platte R, Hopper Jl, Southey Mc, et al
Human molecular genetics 2011;20(23):4693-706

Breast cancer susceptibility polymorphisms and endometrial cancer risk: a Collaborative Endometrial Cancer Study
Healey Cs, Ahmed S, Anecs, Aocs Management Group, O'mara Ta, Ferguson K, et al
Carcinogenesis 2011;32(12):1862-6

Cardiac dose estimates from Danish and Swedish breast cancer radiotherapy during 1977-2001
Taylor Cw, Bronnum D, Darby Sc, Gagliardi G, Hall P, Jensen Mb, et al
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2011;100(2):176-83

Cardiovascular disease associated with radiotherapy: activation of nuclear factor kappa-B
Halle M, Hall P, Tornvall P
Journal of internal medicine 2011;269(5):469-77

Coffee consumption modifies risk of estrogen-receptor negative breast cancer
Li J, Seibold P, Chang-claude J, Flesch-janys D, Liu J, Czene K, et al
Breast cancer research : BCR 2011;13(3):R49-

Common variants in ZNF365 are associated with both mammographic density and breast cancer risk
Lindstrom S, Vachon Cm, Li J, Varghese J, Thompson D, Warren R, et al
Nature genetics 2011;43(3):185-7

Comprehensive long-span paired-end-tag mapping reveals characteristic patterns of structural variations in epithelial cancer genomes
Hillmer Am, Yao F, Inaki K, Lee Wh, Ariyaratne Pn, Teo As, et al
Genome research 2011;21(5):665-75

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
International Multiple Sclerosis Genetics Consortium, Wellcome Trust Case Control Consortium 2, Sawcer S, Hellenthal G, Pirinen M, Spencer Cc, et al
Nature 2011;476(7359):214-9

Genetic variation in the androgen estrogen conversion pathway in relation to breast cancer prognosticators
Darabi H, Czene K, Wedren S, Li Y, Liu J, Hall P, et al
Breast cancer research and treatment 2011;127(2):503-9

Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer
Li Y, Li Y, Wedren S, Li G, Charn Th, Desai Kv, et al
Breast cancer research : BCR 2011;13(1):R10-

Genome-wide association study identifies a common variant associated with risk of endometrial cancer
Spurdle Ab, Thompson Dj, Ahmed S, Ferguson K, Healey Cs, O'mara T, et al
Nature genetics 2011;43(5):451-4

Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden
Mcgale P, Darby Sc, Hall P, Adolfsson J, Bengtsson No, Bennet Am, et al
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2011;100(2):167-75

Long-term cognitive impairment in older adult twins discordant for gynecologic cancer treatment
Kurita K, Meyerowitz Be, Hall P, Gatz M
The journals of gerontology. Series A, Biological sciences and medical sciences 2011;66(12):1343-9

Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium
Broeks A, Schmidt Mk, Sherman Me, Couch Fj, Hopper Jl, Dite Gs, et al
Human molecular genetics 2011;20(16):3289-303

Polymorphisms in oxidative stress-related genes and postmenopausal breast cancer risk
Seibold P, Hein R, Schmezer P, Hall P, Liu J, Dahmen N, et al
International journal of cancer 2011;129(6):1467-76

Progesterone receptor gene variants and risk of endometrial cancer
O'mara Ta, Fahey P, Ferguson K, Marquart L, Lambrechts D, Despierre E, et al
Carcinogenesis 2011;32(3):331-5

Swedish population substructure revealed by genome-wide single nucleotide polymorphism data
Salmela E, Lappalainen T, Liu J, Sistonen P, Andersen Pm, Schreiber S, et al
PloS one 2011;6(2):e16747-

The genetic structure of the Swedish population
Humphreys K, Grankvist A, Leu M, Hall P, Liu J, Ripatti S, et al
PloS one 2011;6(8):e22547-

The role of mammography screening attendance and detection mode in predicting breast cancer survival-is there added prognostic value?
Biesheuvel C, Czene K, Orgeas Cc, Hall P
Cancer epidemiology 2011;35(6):545-50

Transcriptional consequences of genomic structural aberrations in breast cancer
Inaki K, Hillmer Am, Ukil L, Yao F, Woo Xy, Vardy La, et al
Genome research 2011;21(5):676-87

A Dose-response Relationship for the Incidence of Radiation-related Heart Disease
Darby Sc, Bronnum D, Correa C, Ewertz M, Gagliardi G, Gigante B, et al
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 2010;78(3):S49-S50

A genome-wide association scan on estrogen receptor-negative breast cancer
Li J, Humphreys K, Darabi H, Rosin G, Hannelius U, Heikkinen T, et al
Breast cancer research : BCR 2010;12(6):R93-

Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study
Milne Rl, Gaudet Mm, Spurdle Ab, Fasching Pa, Couch Fj, Benitez J, et al
Breast cancer research : BCR 2010;12(6):R110-

Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index
Speliotes Ek, Willer Cj, Berndt Si, Monda Kl, Thorleifsson G, Jackson Au, et al
Nature genetics 2010;42(11):937-48

Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival
Azzato Em, Tyrer J, Fasching Pa, Beckmann Mw, Ekici Ab, Schulz-wendtland R, et al
Journal of the National Cancer Institute 2010;102(9):650-62

Birth weight and mammographic density among postmenopausal women in Sweden
Tamimi Rm, Eriksson L, Lagiou P, Czene K, Ekbom A, Hsieh Cc, et al
International journal of cancer 2010;126(4):985-91

Birth weight, breast cancer susceptibility loci, and breast cancer risk
Tamimi Rm, Lagiou P, Czene K, Liu J, Ekbom A, Hsieh Cc, et al
Cancer causes & control : CCC 2010;21(5):689-96

Diagnostic work-up of contralateral breast cancers has not improved over calendar period
Sandberg Me, Hartman M, Edgren G, Eloranta S, Ploner A, Hall P, et al
Breast cancer research and treatment 2010;122(3):889-95

EFFECT OF ADJUVANT RADIOTHERAPY ON 2: D TUMOR CHARACTERISTICS AND PROGNOSIS OF CONTRALATERAL BREAST CANCER (CBC)
Sandberg Mec, Hartman M, Eloranta S, Ploner A, Hall P, Czene K
AMERICAN JOURNAL OF EPIDEMIOLOGY 2010;:S21-S21

Effects of childhood body size on breast cancer tumour characteristics
Li J, Humphreys K, Eriksson L, Czene K, Liu J, Hall P
Breast cancer research : BCR 2010;12(2):R23-

Genetic variation in the estrogen metabolic pathway and mammographic density as an intermediate phenotype of breast cancer
Li J, Eriksson L, Humphreys K, Czene K, Liu J, Tamimi Rm, et al
Breast cancer research : BCR 2010;12(2):R19-

Hundreds of variants clustered in genomic loci and biological pathways affect human height
Lango Allen H, Estrada K, Lettre G, Berndt Si, Weedon Mn, Rivadeneira F, et al
Nature 2010;467(7317):832-8

I'm so tired: biological and genetic mechanisms of cancer-related fatigue
Barsevick A, Frost M, Zwinderman A, Hall P, Halyard M, Geneqol Consortium
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2010;19(10):1419-27

Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls
Fletcher O, Johnson N, Dos Santos Silva I, Orr N, Ashworth A, Nevanlinna H, et al
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010;19(9):2143-51

Multi-variant pathway association analysis reveals the importance of genetic determinants of estrogen metabolism in breast and endometrial cancer susceptibility
Low Yl, Li Y, Humphreys K, Thalamuthu A, Li Y, Darabi H, et al
PLoS genetics 2010;6(7):e1001012-

Non-participant characteristics and the association between socioeconomic factors and brain tumour risk
Wigertz A, Lonn S, Hall P, Feychting M
Journal of epidemiology and community health 2010;64(8):736-43

NordicDB: a Nordic pool and portal for genome-wide control data
Leu M, Humphreys K, Surakka I, Rehnberg E, Muilu J, Rosenstrom P, et al
European journal of human genetics : EJHG 2010;18(12):1322-6

Pathological confirmation of primary lung cancer following breast cancer
Tennis M, Singh B, Hjerpe A, Prochazka M, Czene K, Hall P, et al
Lung cancer (Amsterdam, Netherlands) 2010;69(1):40-5

Pattern of declining hemoglobin concentration before cancer diagnosis
Edgren G, Bagnardi V, Bellocco R, Hjalgrim H, Rostgaard K, Melbye M, et al
International journal of cancer 2010;127(6):1429-36

Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies
Elks Ce, Perry Jr, Sulem P, Chasman Di, Franceschini N, He C, et al
Nature genetics 2010;42(12):1077-85

A constant risk for familial breast cancer? A population-based family study
Czene K, Reilly M, Hall P, Hartman M
Breast cancer research : BCR 2009;11(3):R30-

A Possible Association between Mammographic Density and Breast Cancer Prognosticators
Eriksson Lk, Czene K, Hall P, Ploner A
CANCER RESEARCH 2009;69(24):702S-702S

Association of ESR1 gene tagging SNPs with breast cancer risk
Dunning Am, Healey Cs, Baynes C, Maia At, Scollen S, Vega A, et al
Human molecular genetics 2009;18(6):1131-9

Breast cancer incidence after hormonal infertility treatment in Sweden: a cohort study
Orgeas Cc, Sanner K, Hall P, Conner P, Holte J, Nilsson Sj, et al
American journal of obstetrics and gynecology 2009;200(1):72.e1-7

Cardiac doses from Swedish breast cancer radiotherapy since the 1950s
Taylor Cw, Nisbet A, Mcgale P, Goldman U, Darby Sc, Hall P, et al
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2009;90(1):127-35

Common genetic variability in ESR1 and EGF in relation to endometrial cancer risk and survival
Einarsdottir K, Darabi H, Czene K, Li Y, Low Yl, Li Yq, et al
British journal of cancer 2009;100(8):1358-64

CYP11A1 Is a Predictor of Mammographic Breast Density
Li J, Eriksson L, Humphreys K, Czene K, Liu J, Hall P
CANCER RESEARCH 2009;69(24):818S-819S

Diagnostic Work-Up of Contralateral Breast Cancers Has Not Improved over Calendar Period.
Sandberg Mec, Hartman M, Hall P, Czene K
CANCER RESEARCH 2009;69(24):709S-710S

Do Asian breast cancer patients have poorer survival than their western counterparts? A comparison between Singapore and Stockholm
Tan Bk, Lim Gh, Czene K, Hall P, Chia Ks
Breast cancer research : BCR 2009;11(1):R4-

Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium
Gaudet Mm, Milne Rl, Cox A, Camp Nj, Goode El, Humphreys Mk, et al
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(5):1610-6

Hyperthyroidism and suicide: a retrospective cohort study in Sweden
Abraham-nordling M, Lonn S, Wallin G, Yin L, Nyren O, Tullgren O, et al
European journal of endocrinology / European Federation of Endocrine Societies 2009;160(3):437-41

Insulin-like growth factor levels in cord blood, birth weight and breast cancer risk
Lagiou P, Hsieh Cc, Lipworth L, Samoli E, Okulicz W, Troisi R, et al
British journal of cancer 2009;100(11):1794-8

Is genetic background important in lung cancer survival?
Lindstrom Ls, Hall P, Hartman M, Wiklund F, Czene K
PloS one 2009;4(5):e5588-

Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2
Ahmed S, Thomas G, Ghoussaini M, Healey Cs, Humphreys Mk, Platte R, et al
Nature genetics 2009;41(5):585-90

No evidence that GATA3 rs570613 SNP modifies breast cancer risk
Johnatty Se, Couch Fj, Fredericksen Z, Tarrell R, Spurdle Ab, Beesley J, et al
Breast cancer research and treatment 2009;117(2):371-9

Nonsmoking: A Surrogate Factor in Primary Lung Cancer in Survivors of Cervical Adenocarcinoma? Reply
Chaturvedi Ak, Kleinerman Ra, Hildesheim A, Gilbert Es, Storm H, Lynch Cf, et al
JOURNAL OF CLINICAL ONCOLOGY 2009;27(18):3066-3067

Obesity and poor breast cancer prognosis: an illusion because of hormone replacement therapy?
Rosenberg L, Czene K, Hall P
British journal of cancer 2009;100(9):1486-91

Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042
Milne Rl, Benitez J, Nevanlinna H, Heikkinen T, Aittomaki K, Blomqvist C, et al
Journal of the National Cancer Institute 2009;101(14):1012-8

Second cancers after squamous cell carcinoma and adenocarcinoma of the cervix
Chaturvedi Ak, Kleinerman Ra, Hildesheim A, Gilbert Es, Storm H, Lynch Cf, et al
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(6):967-73

Simplifying the TNM system for clinical use in differentiated thyroid cancer
Onitilo Aa, Engel Jm, Lundgren Ci, Hall P, Thalib L, Doi Sa
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(11):1872-8

Survival of male breast cancer patients: population-based cohort study
Thalib L, Hall P
Cancer science 2009;100(2):292-5

The establishment of the GENEQOL consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes
Sprangers Ma, Sloan Ja, Veenhoven R, Cleeland Cs, Halyard My, Abertnethy Ap, et al
Twin research and human genetics : the official journal of the International Society for Twin Studies 2009;12(3):301-11

The influence of menopausal hormone therapy on tumour characteristics and survival in endometrial cancer patients
Orgeas Cc, Hall P, Wedren S, Dickman Pw, Czene K
European journal of cancer (Oxford, England : 1990) 2009;45(17):3064-73

Breast cancer onset in twins and women with bilateral disease
Hartman M, Hall P, Edgren G, Reilly M, Lindstrom L, Lichtenstein P, et al
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(25):4086-91

ESR1 and EGF genetic variation in relation to breast cancer risk and survival
Einarsdottir K, Darabi H, Li Y, Low Yl, Li Yq, Bonnard C, et al
Breast cancer research : BCR 2008;10(1):R15-

Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics
Garcia-closas M, Hall P, Nevanlinna H, Pooley K, Morrison J, Richesson Da, et al
PLoS genetics 2008;4(4):e1000054-

"How to treat male breast cancer" (vol 16S2, pg S147, 2007)
Czene K, Bergqvist J, Hall P, Bergh J
BREAST 2008;17(3):319-319

Menopausal hormone therapy in relation to breast cancer characteristics and prognosis: a cohort study
Rosenberg Lu, Granath F, Dickman Pw, Einarsdottir K, Wedren S, Persson I, et al
Breast cancer research : BCR 2008;10(5):R78-

Neonatal growth and breast cancer risk in adulthood
Lagiou P, Hsieh Cc, Trichopoulos D, Adami Ho, Hall P, Chie L, et al
British journal of cancer 2008;99(9):1544-8

Radiation-associated urinary bladder cancer
Hall P
Scandinavian journal of urology and nephrology. Supplementum 2008;(218):85-8

Reproductive factors and risk of meningioma and glioma
Wigertz A, Lonn S, Hall P, Auvinen A, Christensen Hc, Johansen C, et al
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008;17(10):2663-70

Re: Second cancers among 104760 survivors of cervical cancer: Evaluation of long-term risk - Reply
Chaturvedi Ak, Engels Ea, Gilbert Es, Chen Be, Storm H, Lynch Cf, et al
JOURNAL OF THE NATIONAL CANCER INSTITUTE 2008;100(8):600-601

Risk of leukemia among survivors of testicular cancer: a population-based study of 42,722 patients
Howard R, Gilbert E, Lynch Cf, Hall P, Storm H, Holowaty E, et al
Annals of epidemiology 2008;18(5):416-21

The influence of menstrual risk factors on tumor characteristics and survival in postmenopausal breast cancer
Orgeas Cc, Hall P, Rosenberg Lu, Czene K
Breast cancer research : BCR 2008;10(6):R107-

Validation of smoking history in cancer patients
Prochazka M, Hall P, Granath F, Czene K
Acta oncologica (Stockholm, Sweden) 2008;47(6):1004-8

A common coding variant in CASP8 is associated with breast cancer risk
Cox A, Dunning Am, Garcia-closas M, Balasubramanian S, Reed Mw, Pooley Ka, et al
Nature genetics 2007;39(3):352-8

[After the Chernobyl accident: no basis for increased cancer risk in Sweden]
Holm Le, Hall P, Ekbom A
Läkartidningen 2007;104(44):3253-4

Allergic conditions and brain tumor risk
Wigertz A, Lonn S, Schwartzbaum J, Hall P, Auvinen A, Christensen Hc, et al
American journal of epidemiology 2007;166(8):941-50

Are cancer risks associated with exposures to ionising radiation from internal emitters greater than those in the Japanese A-bomb survivors?
Little Mp, Hall P, Charles Mw
Radiation and environmental biophysics 2007;46(4):299-310

Effect of ATM, CHEK2 and ERBB2 TAGSNPs and haplotypes on endometrial cancer risk
Einarsdottir K, Humphreys K, Bonnard C, Li Y, Li Y, Chia Ks, et al
Human molecular genetics 2007;16(2):154-64

Familial concordance in cancer survival: a Swedish population-based study
Lindstrom Ls, Hall P, Hartman M, Wiklund F, Gronberg H, Czene K
The Lancet. Oncology 2007;8(11):1001-6

Gene expression in 16q is associated with survival and differs between Sørlie breast cancer subtypes
Wennmalm K, Calza S, Ploner A, Hall P, Bjohle J, Klaar S, et al
Genes, chromosomes & cancer 2007;46(1):87-97

Genome-wide association study identifies novel breast cancer susceptibility loci
Easton Df, Pooley Ka, Dunning Am, Pharoah Pd, Thompson D, Ballinger Dg, et al
Nature 2007;447(7148):1087-93

How to treat male breast cancer
Bergqvist J, Czene K, Hall P, Bergh J
BREAST 2007;:S10-S11

Incidence and prognosis of synchronous and metachronous bilateral breast cancer
Hartman M, Czene K, Reilly M, Adolfsson J, Bergh J, Adami Ho, et al
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(27):4210-6

Influence of surgical and postoperative treatment on survival in differentiated thyroid cancer
Lundgren Ci, Hall P, Dickman Pw, Zedenius J
The British journal of surgery 2007;94(5):571-7

Is breast cancer prognosis inherited?
Hartman M, Lindstrom L, Dickman Pw, Adami Ho, Hall P, Czene K
Breast cancer research : BCR 2007;9(3):R39-

Leukemia following breast cancer: an international population-based study of 376,825 women
Howard Ra, Gilbert Es, Chen Be, Hall P, Storm H, Pukkala E, et al
Breast cancer research and treatment 2007;105(3):359-68

Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma
Hodgson Dc, Gilbert Es, Dores Gm, Schonfeld Sj, Lynch Cf, Storm H, et al
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(12):1489-97

Noncancer causes of death in survivors of testicular cancer
Fossa Sd, Gilbert E, Dores Gm, Chen J, Mcglynn Ka, Schonfeld S, et al
Journal of the National Cancer Institute 2007;99(7):533-44

Risk of second non-hematological malignancies among 376,825 breast cancer survivors
Brown Lm, Chen Be, Pfeiffer Rm, Schairer C, Hall P, Storm H, et al
Breast cancer research and treatment 2007;106(3):439-51

Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk
Chaturvedi Ak, Engels Ea, Gilbert Es, Chen Be, Storm H, Lynch Cf, et al
Journal of the National Cancer Institute 2007;99(21):1634-43

[Swedish clinical research offers unique basic conditions--use them!]
Hall P
Läkartidningen 2007;104(14-15):1167-

Acute myeloid leukemia following Hodgkin lymphoma: a population-based study of 35,511 patients
Schonfeld Sj, Gilbert Es, Dores Gm, Lynch Cf, Hodgson Dc, Hall P, et al
Journal of the National Cancer Institute 2006;98(3):215-8

Are possible risk factors for differentiated thyroid cancer of prognostic importance?
Ihre Lundgren C
Thyroid : official journal of the American Thyroid Association 2006;16(7):659-66

Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study
Lundgren Ci, Hall P, Dickman Pw, Zedenius J
Cancer 2006;106(3):524-31

Comprehensive analysis of the ATM, CHEK2 and ERBB2 genes in relation to breast tumour characteristics and survival: a population-based case-control and follow-up study
Einarsdottir K, Rosenberg Lu, Humphreys K, Bonnard C, Palmgren J, Li Y, et al
Breast cancer research : BCR 2006;8(6):R67-

Ethnic differences in the time trend of female breast cancer incidence: Singapore, 1968-2002
Sim X, Ali Ra, Wedren S, Goh Dl, Tan Cs, Reilly M, et al
BMC cancer 2006;6():261-

Family history of breast cancer and young age at diagnosis of breast cancer increase risk of second primary malignancies in women: a population-based cohort study
Prochazka M, Hall P, Granath F, Czene K
British journal of cancer 2006;95(9):1291-5

Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer
Ivshina Av, George J, Senko O, Mow B, Putti Tc, Smeds J, et al
Cancer research 2006;66(21):10292-301

Genomic instability and prognosis in breast carcinomas
Kronenwett U, Ploner A, Zetterberg A, Bergh J, Hall P, Auer G, et al
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(9):1630-5

Hormone-replacement therapy influences gene expression profiles and is associated with breast-cancer prognosis: a cohort study
Hall P, Ploner A, Bjohle J, Huang F, Lin Cy, Liu Et, et al
BMC medicine 2006;4():16-

Incidence and prognosis of synchronous and metachronous bilateral breast cancer.
Hartman M, Czene K, Reilly M, Adami Ho, Hall P
BREAST CANCER RESEARCH AND TREATMENT 2006;:S273-S273

Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients
Calza S, Hall P, Auer G, Bjohle J, Klaar S, Kronenwett U, et al
Breast cancer research : BCR 2006;8(4):R34-

Ionizing radiation and tobacco use increases the risk of a subsequent lung carcinoma in women with breast cancer: Case-only design
Prochazka M, Hall P, Gagliardi G, Granath F, Nilsson Bn, Shields Pg, et al
RADIOTHERAPY AND ONCOLOGY 2006;:S286-S286

Is breast cancer prognosis inherited?
Hartman M, Lindstrom L, Dickman Pw, Hall P, Czene K
BREAST CANCER RESEARCH AND TREATMENT 2006;:S185-S185

Linkage disequilibrium mapping of CHEK2: common variation and breast cancer risk
Einarsdottir K, Humphreys K, Bonnard C, Palmgren J, Iles Mm, Sjolander A, et al
PLoS medicine 2006;3(6):e168-

Linkage disequilibrium mapping of CHEK2: Common variation and breast cancer risk
Einarsdottir K, Humphreys K, Bonnard C, Palmgren J, Iles Mm, Sjolander A, et al
PLOS MEDICINE 2006;3(6):895-903

Menopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer: a case-control study
Rosenberg Lu, Magnusson C, Lindstrom E, Wedren S, Hall P, Dickman Pw
Breast cancer research : BCR 2006;8(1):R11-

p53 Mutation analysis in breast tumors by a DNA microarray method
Tennis M, Krishnan S, Bonner M, Ambrosone Cb, Vena Je, Moysich K, et al
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(1):80-5

Risk factors for hormone receptor-defined breast cancer in postmenopausal women
Rosenberg Lu, Einarsdottir K, Friman Ei, Wedren S, Dickman Pw, Hall P, et al
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(12):2482-8

Risk of brain tumors associated with exposure to exogenous female sex hormones
Wigertz A, Lonn S, Mathiesen T, Ahlbom A, Hall P, Feychting M, et al
American journal of epidemiology 2006;164(7):629-36

Sex of first child and breast cancer survival: a population-based study
Thalib L, Hall P
International journal of cancer 2006;118(6):1515-8

Suicide after breast cancer: an international population-based study of 723,810 women
Schairer C, Brown Lm, Chen Be, Howard R, Lynch Cf, Hall P, et al
Journal of the National Cancer Institute 2006;98(19):1416-9

Thyroid abnormalities associated with protracted childhood exposure to 131I from atmospheric emissions from the Mayak weapons facility in Russia
Mushkacheva G, Rabinovich E, Privalov V, Povolotskaya S, Shorokhova V, Sokolova S, et al
Radiation research 2006;166(5):715-22

Acute leukemia (AL) following Hodgkin's lymphoma (HL): A population-based study of over 38,000 patients
Schonfeld Sj, Gilbert Es, Dores Gm, Lynch Cf, Holowaty E, Hall P, et al
JOURNAL OF CLINICAL ONCOLOGY 2005;23(16):562S-562S

An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival
Miller Ld, Smeds J, George J, Vega Vb, Vergara L, Ploner A, et al
Proceedings of the National Academy of Sciences of the United States of America 2005;102(38):13550-5

Cancer as a risk factor for long-term cognitive deficits and dementia
Heflin Lh, Meyerowitz Be, Hall P, Lichtenstein P, Johansson B, Pedersen Nl, et al
Journal of the National Cancer Institute 2005;97(11):854-6

Can we trust cancer information on the Internet?--A comparison of interactive cancer risk sites
Ekman A, Hall P, Litton Je
Cancer causes & control : CCC 2005;16(6):765-72

Coronary angioplasty and cancer risk: a population-based cohort study in Sweden
Lambe M, Hall P, Granath F, Sadr Azodi O, Nilsson T
Cardiovascular and interventional radiology 2005;28(1):36-8

Correlation test to assess low-level processing of high-density oligonucleotide microarray data
Ploner A, Miller Ld, Hall P, Bergh J, Pawitan Y
BMC bioinformatics 2005;6():80-

CYP17 gene polymorphism in relation to breast cancer risk: a case-control study
Einarsdottir K, Rylander-rudqvist T, Humphreys K, Ahlberg S, Jonasdottir G, Weiderpass E, et al
Breast cancer research : BCR 2005;7(6):R890-6

Epidemiology of cancer-related fatigue in the Swedish twin registry
Forlenza Mj, Hall P, Lichtenstein P, Evengard B, Sullivan Pf
Cancer 2005;104(9):2022-31

Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts
Pawitan Y, Bjohle J, Amler L, Borg Al, Egyhazi S, Hall P, et al
Breast cancer research : BCR 2005;7(6):R953-64

Gene profile and response to treatment
Smeds J, Miller Ld, Bjohle J, Hall P, Klaar S, Liu Et, et al
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16 Suppl 2():ii195-202

Gene profile and response to treatment
Smeds J, Miller Ld, Bjohle J, Hall P, Klaar S, Liu Et, et al
ANNALS OF ONCOLOGY 2005;:195-202

Genetic implications of bilateral breast cancer: a population based cohort study
Hartman M, Czene K, Reilly M, Bergh J, Lagiou P, Trichopoulos D, et al
The Lancet. Oncology 2005;6(6):377-82

[Increased number of cancer cases following computer tomography in children. Radiation dosage--and cancer risk--can be reduced]
Hall P, Fransson A, Martens A, Johanson L, Leitz W, Granath F
Läkartidningen 2005;102(4):214-5

Ionizing radiation and tobacco use increases the risk of a subsequent lung carcinoma in women with breast cancer: case-only design
Prochazka M, Hall P, Gagliardi G, Granath F, Nilsson Bn, Shields Pg, et al
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(30):7467-74

Long-term cause-specific mortality among 41,146 one-year survivors of Hodgkin lymphoma (HL)
Nci-int Hodgkin Lymphoma Grp, Dores G, Schonfeld S, Chen J, Hodgson D, Fossa S, et al
JOURNAL OF CLINICAL ONCOLOGY 2005;23(16):562S-562S

Long-term mobile phone use and brain tumor risk
Lonn S, Ahlbom A, Hall P, Feychting M, Swedish Interphone Study Group
American journal of epidemiology 2005;161(6):526-35

Mobile phone use and acoustic neuromas - Response
Lonn S, Ahlbom A, Hall P, Feychting M
EPIDEMIOLOGY 2005;16(3):417-418

Multiple births and breast cancer prognosis: a population based study
Thalib L, Doi Sa, Hall P
European journal of epidemiology 2005;20(7):613-7

Parathyroid adenoma and primary CNS tumors
Backlund Lm, Grander D, Brandt L, Hall P, Ekbom A
International journal of cancer 2005;113(6):866-9

Profound changes in breast cancer incidence may reflect changes into a Westernized lifestyle: a comparative population-based study in Singapore and Sweden
Chia Ks, Reilly M, Tan Cs, Lee J, Pawitan Y, Adami Ho, et al
International journal of cancer 2005;113(2):302-6

Re: Cancer as a risk factor for dementia: a house built on shifting sand
Heflin Lh, Meyerowitz Be, Hall P, Lichtenstein P, Johansson B, Pedersen Nl, et al
Journal of the National Cancer Institute 2005;97(20):1550-1

Re: Cancer as a risk factor for long-term cognitive deficits and dementia - Response
Heflin Lh, Meyerowitz Be, Hall P, Lichtenstein P, Johansson B, Pedersen Nl, et al
JOURNAL OF THE NATIONAL CANCER INSTITUTE 2005;97(20):1550-1550

Re: "Long-term mobile phone use and brain tumor risk" - The authors reply
Lonn S, Ahlbom A, Hall P, Feychting M
AMERICAN JOURNAL OF EPIDEMIOLOGY 2005;162(6):601-601

Second cancers among 40,576 testicular cancer patients: focus on long-term survivors
Travis Lb, Fossa Sd, Schonfeld Sj, Mcmaster Ml, Lynch Cf, Storm H, et al
Journal of the National Cancer Institute 2005;97(18):1354-65

Breast cancer prognosis in relation to family history of breast and ovarian cancer
Thalib L, Wedren S, Granath F, Adami Ho, Rydh B, Magnusson C, et al
British journal of cancer 2004;90(7):1378-81

Childbirth and breast cancer prognosis
Rosenberg L, Thalib L, Adami Ho, Hall P
International journal of cancer 2004;111(5):772-6

[Computer tomography of the cranium in children--risk assessment]
Flodmark O, Hall P, Ingvar M
Läkartidningen 2004;101(8):706-7

Effect of low doses of ionising radiation in infancy on cognitive function in adulthood: Swedish population based cohort study
Hall P, Adami Ho, Trichopoulos D, Pedersen Nl, Lagiou P, Ekbom A, et al
BMJ (Clinical research ed.) 2004;328(7430):19-

Gene expression profiling for prognosis using Cox regression
Pawitan Y, Bjohle J, Wedren S, Humphreys K, Skoog L, Huang F, et al
Statistics in medicine 2004;23(11):1767-80

Incidence trends of adult primary intracerebral tumors in four Nordic countries
Lonn S, Klaeboe L, Hall P, Mathiesen T, Auvinen A, Christensen Hc, et al
International journal of cancer 2004;108(3):450-5

Ionising radiation in infancy and adult cognitive function - Reply
Hall P, Lundell M
BRITISH MEDICAL JOURNAL 2004;328(7439):582-582

Mobile phone use and the risk of acoustic neuroma
Lonn S, Ahlbom A, Hall P, Feychting M
Epidemiology (Cambridge, Mass.) 2004;15(6):653-9

Preoperative psychological reactions and quality of life among women with an increased risk of breast cancer who are considering a prophylactic mastectomy
Brandberg Y, Arver B, Lindblom A, Sandelin K, Wickman M, Hall P
European journal of cancer (Oxford, England : 1990) 2004;40(3):365-74

Risk of non-Hodgkin's lymphoma and skin malignancies in patients diagnosed with cataract
Boldeman C, Brandt L, Berg L, Ekbom A, Hall P
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2004;13(4):281-5

A biologically based model for liver cancer risk in the Swedish thorotrast patients
Heidenreich Wf, Nyberg U, Hall P
Radiation research 2003;159(5):656-62

Incidence and survival of Swedish patients with differentiated thyroid cancer
Lundgren Ci, Hall P, Ekbom A, Frisell J, Zedenius J, Dickman Pw
International journal of cancer 2003;106(4):569-73

Mortality from cardiovascular disease more than 10 years after radiotherapy for breast cancer: nationwide cohort study of 90 000 Swedish women
Darby S, Mcgale P, Peto R, Granath F, Hall P, Ekbom A
BMJ (Clinical research ed.) 2003;326(7383):256-7

Risk of ovarian cancer in breast-cancer patients with a family history of either - Reply
Bergfeldt K, Hall P
LANCET 2003;361(9352):179-180

Second primary malignancies in thyroid cancer patients
Rubino C, De Vathaire F, Dottorini Me, Hall P, Schvartz C, Couette Je, et al
British journal of cancer 2003;89(9):1638-44

Site-specific cancer incidence and mortality after cerebral angiography with radioactive thorotrast
Travis Lb, Hauptmann M, Gaul Lk, Storm Hh, Goldman Mb, Nyberg U, et al
Radiation research 2003;160(6):691-706

Thyroid cancer risk after thyroid examination with 131I: a population-based cohort study in Sweden
Dickman Pw, Holm Le, Lundell G, Boice Jd, Hall P
International journal of cancer 2003;106(4):580-7

Cancer incidence among Swedish patients exposed to radioactive thorotrast: a forty-year follow-up survey
Nyberg U, Nilsson B, Travis Lb, Holm Le, Hall P
Radiation research 2002;157(4):419-25

Cause-of-death registers in radiation-contaminated areas of the Russian Federation and Kazakhstan
Winkelmann Ra, Tretyakov Fd, Startsev Nv, Kolyado Ib, Gusev Bi, Grosche B, et al
Radiation and environmental biophysics 2002;41(1):5-11

Lung cancer risks in women with previous breast cancer
Prochazka M, Granath F, Ekbom A, Shields Pg, Hall P
European journal of cancer (Oxford, England : 1990) 2002;38(11):1520-5

Microarray studies on a population based breast cancer cohort - search for gene profiles with prognostic and predictive value.
Bjohle J, Pawitan Y, Skoog L, Shaw P, Amler L, Humphreys K, et al
BREAST CANCER RESEARCH AND TREATMENT 2002;:S29-S29

p53 mutations in leukemia and myelodysplastic syndrome after ovarian cancer
Leonard Dg, Travis Lb, Addya K, Dores Gm, Holowaty Ej, Bergfeldt K, et al
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(5):973-85

Risk of childhood leukaemia in the vicinity of nuclear installations--findings and recent controversies
Laurier D, Grosche B, Hall P
Acta oncologica (Stockholm, Sweden) 2002;41(1):14-24

Risk of ovarian cancer in breast-cancer patients with a family history of breast or ovarian cancer: a population-based cohort study
Bergfeldt K, Rydh B, Granath F, Gronberg H, Thalib L, Adami Ho, et al
Lancet (London, England) 2002;360(9337):891-4

Studies on the Ozyorsk population: health effects
Koshurnikova Na, Mushkacheva Gs, Shilnikova Ns, Rabinovich Ei, Petrushkina Np, Hall P, et al
Radiation and environmental biophysics 2002;41(1):37-9

Studies on the Techa river offspring cohort: health effects
Kossenko Mm, Ostroumova E, Granath F, Hall P
Radiation and environmental biophysics 2002;41(1):49-52

[Are there any hazards connected to cerebral computer tomography?]
Hall P
Läkartidningen 2001;98(14):1714-

Breast cancer risk in women with a primary ovarian cancer--a case-control study
Bergfeldt K, Nilsson B, Einhorn S, Hall P
European journal of cancer (Oxford, England : 1990) 2001;37(17):2229-34

Intrauterine exposure to diagnostic X rays and risk of childhood leukemia subtypes
Naumburg E, Bellocco R, Cnattingius S, Hall P, Boice Jd, Ekbom A
Radiation research 2001;156(6):718-23

Mortality after cerebral angiography with or without radioactive Thorotrast: an international cohort of 3,143 two-year survivors
Travis Lb, Land Ce, Andersson M, Nyberg U, Goldman Mb, Knudson Gaul L, et al
Radiation research 2001;156(2):136-50

[Comment to an article in Lakartidningen: How much does a patient want to know?]
Hall P
Läkartidningen 2000;97(43):4884-

Mortality in the offspring of individuals living along the radioactively contaminated Techa River: a descriptive analysis
Kossenko Mm, Ostroumova Y, Akleyev A, Startsev N, Degteva M, Granath F, et al
Radiation and environmental biophysics 2000;39(4):219-25

Overestimated risk of second primary malignancies in ovarian cancer patients
Bergfeldt K, Silfversward C, Einhorn S, Hall P
European journal of cancer (Oxford, England : 1990) 2000;36(1):100-5

Prenatal ultrasound examinations and risk of childhood leukaemia: case-control study
Naumburg E, Bellocco R, Cnattingius S, Hall P, Ekbom A
BMJ (Clinical research ed.) 2000;320(7230):282-3

Treatment-associated leukemia following testicular cancer
Travis Lb, Andersson M, Gospodarowicz M, Van Leeuwen Fe, Bergfeldt K, Lynch Cf, et al
Journal of the National Cancer Institute 2000;92(14):1165-71

[Increasing competition: ten good suggestions for how to apply for research funds!]
Pedersen N, Adami Ho, Hall P
Läkartidningen 1999;96(15):1855-8

Lenticular opacities in individuals exposed to ionizing radiation in infancy
Hall P, Granath F, Lundell M, Olsson K, Holm Le
Radiation research 1999;152(2):190-5

Mortality after long-term exposure to radioactive Thorotrast: a forty-year follow-up survey in Sweden
Martling U, Mattsson A, Travis Lb, Holm Le, Hall P
Radiation research 1999;151(3):293-9

Risk of leukemia after platinum-based chemotherapy for ovarian cancer
Travis Lb, Holowaty Ej, Bergfeldt K, Lynch Cf, Kohler Ba, Wiklund T, et al
The New England journal of medicine 1999;340(5):351-7

Radiation-associated thyroid cancer--facts and fiction
Hall P, Holm Le
Acta oncologica (Stockholm, Sweden) 1998;37(4):325-30

Incidence of primary malignancies other than breast cancer among women treated with radiation therapy for benign breast disease
Mattsson A, Hall P, Ruden Bi, Rutqvist Le
Radiation research 1997;148(2):152-60

Late consequences of radioiodine for diagnosis and therapy in Sweden
Hall P, Holm Le
Thyroid : official journal of the American Thyroid Association 1997;7(2):205-8

Risk of second malignant neoplasms among long-term survivors of testicular cancer
Travis Lb, Curtis Re, Storm H, Hall P, Holowaty E, Van Leeuwen Fe, et al
Journal of the National Cancer Institute 1997;89(19):1429-39

Graves' hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine--a prospective, randomized study. Thyroid Study Group
Torring O, Tallstedt L, Wallin G, Lundell G, Ljunggren Jg, Taube A, et al
The Journal of clinical endocrinology and metabolism 1996;81(8):2986-93

Thyroid cancer after diagnostic administration of iodine-131
Hall P, Mattsson A, Boice Jd
Radiation research 1996;145(1):86-92

Thyroid nodularity after diagnostic administration of iodine-131
Hall P, Furst Cj, Mattsson A, Holm Le, Boice Jd, Inskip Pd
Radiation research 1996;146(6):673-82

CANCER INCIDENCE AND MORTALITY AFTER I-131 THERAPY FOR HYPERTHYROIDISM
Hall P, Holm Le
RADIATION AND PUBLIC PERCEPTION 1995;:103-112

Cancer in iodine-131 exposed patients
Hall P, Holm Le
Journal of endocrinological investigation 1995;18(2):147-9

Increased risk of second primary malignancies in patients with gynecological cancer. A Swedish record-linkage study
Bergfeldt K, Einhorn S, Rosendahl I, Hall P
Acta oncologica (Stockholm, Sweden) 1995;34(6):771-7

Non-Hodgkin's lymphoma and skin malignancies--shared etiology?
Hall P, Rosendahl I, Mattsson A, Einhorn S
International journal of cancer 1995;62(5):519-22

Show all publications